EVALUATION OF ONE YEAR RESPONSE OF TREATMENT NAIVE CHRONIC HEPATITIS B PATIENTS TO 245 MG/DAY TENOFOVIR DISOPROXIL FUMARATE


DEMIR N. A. , KOLGELIER S., DEMIR L. S. , SUMER S., DIKICI N., OZCIMEN S., ...More

NOBEL MEDICUS, vol.9, no.2, pp.57-62, 2013 (Peer-Reviewed Journal) identifier identifier

  • Publication Type: Article / Article
  • Volume: 9 Issue: 2
  • Publication Date: 2013
  • Journal Name: NOBEL MEDICUS
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.57-62

Abstract

Objective: In this study treatment response of 201 chronic hepatitis B (CHB) patients to 245 mg/day tenofovir disoproxil fumarate (TDF) was evaluated upon 48th week of treatment.